Altimmune to Present at Upcoming Investor and Scientific Conferences
November 22 2021 - 4:01PM
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical
company, today announced that members of the Company’s management
team will be presenting virtually at the following conferences:
- Piper Sandler
33rd Annual Virtual Healthcare
ConferenceNovember 29-December 2, 2021Webcast available
now
-
5th Annual NASH Summit
2021November 30, 20219:00 am Eastern Time
-
4th Annual Evercore ISI
HealthCONx ConferenceDecember 2, 202110:55 am Eastern
Time
Presentation materials, including webcast links
to the Piper Sandler and Evercore ISI presentations, will be
accessible on the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical stage biopharmaceutical
company focused on developing treatments for obesity and liver
diseases. Our pipeline includes next generation peptide
therapeutics for obesity, NASH (pemvidutide), and chronic hepatitis
B (HepTcell™). For more information, please visit
www.altimmune.com.
Follow @Altimmune, Inc. on
LinkedInFollow @AltimmuneInc on
Twitter
Altimmune Investor & Media Contact:
Will BrownChief Financial OfficerPhone:
240-654-1450wbrown@altimmune.com
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Oct 2023 to Oct 2024